Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for MLTX

Stock Name	MoonLake Immunotherapeutics
Ticker	MLTX(USD) NASDAQ
TYPE	Common Stock
Country	USA

Show aggregate MLTX holdings

News associated with MLTX

Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) PT at $74.43: Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […] - 2025-09-22 02:42:53
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Rating of “Moderate Buy” from Brokerages: Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 […] - 2025-08-25 02:15:07
MoonLake Immunotherapeutics (NASDAQ:MLTX) Raised to “Hold” at Redburn Atlantic: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was upgraded by research analysts at Redburn Atlantic to a “hold” rating in a report issued on Monday,Zacks.com reports. Several other analysts also recently commented on the stock. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $67.00 price objective on shares of MoonLake Immunotherapeutics in […] - 2025-07-30 02:20:44
MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Up 2.7% – Still a Buy?: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) shares traded up 2.7% during trading on Wednesday . The stock traded as high as $48.02 and last traded at $47.86. 425,225 shares were traded during mid-day trading, an increase of 11% from the average session volume of 384,204 shares. The stock had previously closed at $46.61. Wall […] - 2025-07-03 04:28:52
The Math Shows ESML Can Go To $48: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-18 08:03:21
MoonLake Immunotherapeutics (NASDAQ:MLTX) Earns “Outperform” Rating from Royal Bank of Canada: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $67.00 price objective on the stock. Royal Bank of Canada’s target price points to a potential upside of […] - 2025-06-05 02:29:04
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 15:06:39
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 14:07:37
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 12:48:38
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 10:35:23
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 08:48:55
Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 20,141 MoonLake Immunotherapeutics (NASDAQ:MLTX): Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 20,141 shares of the company’s stock, valued at approximately $1,091,000. Several other hedge funds also recently added to or reduced their stakes in the stock. Deutsche Bank AG […] - 2025-06-04 05:24:49
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 03:47:05
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-03 23:49:46
Stocks Climb as Chip Makers Rally and US Job Openings Increase: The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 18:26:24
Stocks Climb as Chip Makers Rally and US Job Openings Increase: The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 14:47:08
MoonLake Immunotherapeutics Breaks Above 200-Day Moving Average - Bullish for MLTX: In trading on Tuesday, shares of MoonLake Immunotherapeutics (Symbol: MLTX) crossed above their 200 day moving average of $45.66, changing hands as high as $49.48 per share. MoonLake Immunotherapeutics shares are currently trading up about 18.7% on the day. The chart below sho - 2025-06-03 14:16:02
Stocks Climb as Chip Makers Rally and US Job Openings Increase: The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 14:05:31
Stocks See Support as Bond Yields Slide: The S&P 500 Index ($SPX ) (SPY ) today is up +0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. June E-mini S&P futures (ESM25 ) are up +0.07%, and June E-mini Nasdaq futures... - 2025-06-03 12:50:06
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.: MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 13.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,456 shares of the company’s stock after purchasing an additional 1,866 shares during the period. […] - 2025-05-27 04:47:04
Nuveen Asset Management LLC Boosts Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX): Nuveen Asset Management LLC increased its stake in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 595,581 shares of the company’s stock after purchasing an additional 14,792 shares during the quarter. Nuveen Asset Management LLC […] - 2025-05-22 05:58:59
Wolfe Research Upgrades MoonLake Immunotherapeutics (NASDAQ:MLTX) to Outperform: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating in a report released on Monday, MarketBeat Ratings reports. The firm presently has a $61.00 price target on the stock. Wolfe Research’s price objective would indicate a potential upside of 51.44% from […] - 2025-05-21 02:42:44
Ameriprise Financial Inc. Boosts Stake in MoonLake Immunotherapeutics (NASDAQ:MLTX): Ameriprise Financial Inc. boosted its position in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 28.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 204,373 shares of the company’s stock after purchasing an additional 45,113 shares during the period. Ameriprise […] - 2025-05-19 04:30:54
Dimensional Fund Advisors LP Takes Position in MoonLake Immunotherapeutics (NASDAQ:MLTX): Dimensional Fund Advisors LP acquired a new stake in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm acquired 64,384 shares of the company’s stock, valued at approximately $3,485,000. A number of other institutional investors and hedge funds have also made changes to their positions in MLTX. PNC Financial […] - 2025-05-14 04:32:47
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $80.50 Consensus Price Target from Analysts: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. […] - 2025-04-25 02:52:47
MoonLake Immunotherapeutics (NASDAQ:MLTX) Sets New 12-Month Low – What’s Next?: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) hit a new 52-week low during trading on Monday . The stock traded as low as $34.13 and last traded at $35.04, with a volume of 339603 shares. The stock had previously closed at $37.21. Analyst Ratings Changes MLTX has been the topic of a number of recent […] - 2025-04-08 04:50:55
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $80.50 Average PT from Analysts: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned an average rating of “Buy” from the eight brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. […] - 2025-03-31 02:46:59
MoonLake Immunotherapeutics (NASDAQ:MLTX) Now Covered by Royal Bank of Canada: Royal Bank of Canada assumed coverage on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a research report released on Tuesday, Marketbeat.com reports. The brokerage issued an outperform rating and a $67.00 price target on the stock. Several other analysts have also recently commented on the company. HC Wainwright reissued a “buy” rating and […] - 2025-03-19 05:12:49
ESGV's Underlying Holdings Imply 20% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-10 09:44:02
Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) PT at $83.20: Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have earned a consensus recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-03-06 04:45:40

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MLTX holdings

Date	Number of MLTX Shares Held	Base Market Value of MLTX Shares	Local Market Value of MLTX Shares	Change in MLTX Shares Held	Change in MLTX Base Value	Current Price per MLTX Share Held	Previous Price per MLTX Share Held
2025-11-12 (Wednesday)	21,847	USD 278,986	USD 278,986	-72	USD 21,438	USD 12.77	USD 11.75
2025-11-11 (Tuesday)	21,919	USD 257,548	USD 257,548	0	USD 20,384	USD 11.75	USD 10.82
2025-11-10 (Monday)	21,919	USD 237,164	USD 237,164	0	USD 4,165	USD 10.82	USD 10.63
2025-11-07 (Friday)	21,919	USD 232,999	USD 232,999	0	USD 7,452	USD 10.63	USD 10.29
2025-11-06 (Thursday)	21,919	USD 225,547	USD 225,547	-72	USD -7,338	USD 10.29	USD 10.59
2025-11-05 (Wednesday)	21,991	USD 232,885	USD 232,885	-720	USD 2,823	USD 10.59	USD 10.13
2025-11-04 (Tuesday)	22,711	USD 230,062	USD 230,062	-144	USD -3,059	USD 10.13	USD 10.2
2025-11-03 (Monday)	22,855	USD 233,121	USD 233,121	-144	USD 831	USD 10.2	USD 10.1
2025-10-31 (Friday)	22,999	USD 232,290	USD 232,290	0	USD 6,670	USD 10.1	USD 9.80999
2025-10-30 (Thursday)	22,999	USD 225,620	USD 225,620	0	USD 4,600	USD 9.80999	USD 9.60998
2025-10-29 (Wednesday)	22,999	USD 221,020	USD 221,020	0	USD -4,830	USD 9.60998	USD 9.81999
2025-10-28 (Tuesday)	22,999	USD 225,850	USD 225,850	216	USD -3,575	USD 9.81999	USD 10.07
2025-10-27 (Monday)	22,783	USD 229,425	USD 229,425	0	USD 12,531	USD 10.07	USD 9.51999

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MLTX by Blackrock for IE00B3VWM098

Show aggregate share trades of MLTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 SELL -72 12.840 11.770 11.877 USD -855 40.18 Profit of 2,038 on sale
2025-11-06 SELL -72 10.630 10.020 10.081 USD -726 40.79 Profit of 2,211 on sale
2025-11-05 SELL -720 10.750 10.010 10.084 USD -7,260 40.95 Profit of 22,220 on sale
2025-11-04 SELL -144 10.598 10.000 10.060 USD -1,449 41.11 Profit of 4,471 on sale
2025-11-03 SELL -144 10.550 10.063 10.112 USD -1,456 41.27 Profit of 4,487 on sale
2025-10-28 BUY 216 9.820 10.110 10.081 USD 2,177 41.95
2025-10-24 SELL -72 9.520 9.700 9.682 USD -697 42.30 Profit of 2,349 on sale
2025-10-15 BUY 432 9.890 10.250 10.214 USD 4,412 43.61
2025-10-02 BUY 72 7.460 7.460 7.460 USD 537 44.02
2025-09-30 BUY 144 7.170 7.480 7.449 USD 1,073 44.45
2025-08-21 SELL -72 54.170 54.620 54.575 USD -3,929 44.40 Loss of -732 on sale
2025-07-31 BUY 216 50.440 51.590 51.475 USD 11,119 44.31
2025-06-30 SELL -144 47.200 48.490 48.361 USD -6,964 43.49 Loss of -701 on sale
2025-06-25 SELL -72 47.370 47.430 47.424 USD -3,415 43.41 Loss of -289 on sale
2025-06-20 SELL -144 43.500 44.000 43.950 USD -6,329 43.38 Loss of -82 on sale
2025-05-23 BUY 72 38.930 39.080 39.065 USD 2,813 43.39
2025-05-19 SELL -72 39.200 40.490 40.361 USD -2,906 43.53 Profit of 228 on sale
2025-05-15 SELL -216 37.660 37.760 37.750 USD -8,154 43.64 Profit of 1,271 on sale
2025-05-12 SELL -72 40.180 40.860 40.792 USD -2,937 43.77 Profit of 215 on sale
2025-05-09 SELL -72 38.470 40.750 40.522 USD -2,918 43.82 Profit of 237 on sale
2025-04-30 SELL -72 42.080 42.540 42.494 USD -3,060 44.04 Profit of 111 on sale
2025-04-24 SELL -144 39.450 40.065 40.003 USD -5,761 44.22 Profit of 607 on sale
2025-04-17 SELL -72 38.325 38.370 38.365 USD -2,762 44.49 Profit of 441 on sale
2025-04-15 SELL -216 36.770 36.980 36.959 USD -7,983 44.66 Profit of 1,663 on sale
2025-04-14 SELL -216 35.750 36.740 36.641 USD -7,914 44.75 Profit of 1,752 on sale
2025-04-09 SELL -288 35.980 36.970 36.871 USD -10,619 45.09 Profit of 2,367 on sale
2025-04-07 SELL -504 34.780 37.310 37.057 USD -18,677 45.35 Profit of 4,180 on sale
2025-04-04 SELL -720 37.210 38.560 38.425 USD -27,666 45.45 Profit of 5,055 on sale
2025-03-31 BUY 72 39.070 40.685 40.524 USD 2,918 45.73
2025-03-19 SELL -144 39.920 40.350 40.307 USD -5,804 46.36 Profit of 871 on sale
2025-03-14 SELL -432 38.550 39.200 39.135 USD -16,906 46.67 Profit of 3,255 on sale
2025-03-13 SELL -144 37.820 39.435 39.274 USD -5,655 46.80 Profit of 1,083 on sale
2025-03-12 SELL -2,448 39.310 39.830 39.778 USD -97,377 46.90 Profit of 17,445 on sale
2025-03-07 SELL -144 38.035 40.170 39.956 USD -5,754 47.33 Profit of 1,062 on sale
2025-03-06 SELL -216 39.820 40.590 40.513 USD -8,751 47.45 Profit of 1,498 on sale
2025-03-03 SELL -72 39.710 42.505 42.226 USD -3,040 47.81 Profit of 402 on sale
2025-02-28 SELL -432 41.760 42.560 42.480 USD -18,351 47.91 Profit of 2,344 on sale
2025-02-26 SELL -72 42.370 42.910 42.856 USD -3,086 48.10 Profit of 378 on sale
2025-02-25 SELL -216 40.730 41.360 41.297 USD -8,920 48.23 Profit of 1,498 on sale
2025-02-18 BUY 360 42.825 44.570 44.395 USD 15,982 48.82
2025-02-13 BUY 72 43.600 45.010 44.869 USD 3,231 49.15
2025-02-12 BUY 72 44.270 44.390 44.378 USD 3,195 49.25
2025-02-11 BUY 216 43.230 43.940 43.869 USD 9,476 49.37
2025-02-06 BUY 648 47.110 48.220 48.109 USD 31,175 49.63
2025-01-27 BUY 72 44.890 46.750 46.564 USD 3,353 50.54
2024-12-30 BUY 360 53.020 55.500 55.252 USD 19,891 50.63
2024-12-06 BUY 288 54.310 55.035 54.963 USD 15,829 50.33
2024-12-05 BUY 72 53.500 54.000 53.950 USD 3,884 50.22
2024-12-04 BUY 360 53.060 54.540 54.392 USD 19,581 50.12
2024-11-29 BUY 360 54.430 55.370 55.276 USD 19,899 49.69
2024-11-27 BUY 288 54.240 54.600 54.564 USD 15,714 49.29
2024-11-26 BUY 72 52.840 54.330 54.181 USD 3,901 49.13
2024-11-25 SELL -2,201 54.170 55.810 55.646 USD -122,477 48.89 Loss of -14,874 on sale
2024-11-21 BUY 393 51.860 52.090 52.067 USD 20,462 48.45
2024-11-20 BUY 234 49.820 50.980 50.864 USD 11,902 48.37
2024-11-18 BUY 936 48.540 49.290 49.215 USD 46,065 48.30
2024-11-12 BUY 624 51.890 54.810 54.518 USD 34,019 48.06
2024-11-08 BUY 390 51.780 52.000 51.978 USD 20,271 47.79
2024-11-07 BUY 1,170 50.670 52.340 52.173 USD 61,042 47.57
2024-11-06 BUY 156 51.480 51.670 51.651 USD 8,058 47.25
2024-10-31 BUY 78 46.420 47.030 46.969 USD 3,664 47.47
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	SELL	-72	12.840	11.770	11.877	USD -855	40.18 Profit of 2,038 on sale
2025-11-06	SELL	-72	10.630	10.020	10.081	USD -726	40.79 Profit of 2,211 on sale
2025-11-05	SELL	-720	10.750	10.010	10.084	USD -7,260	40.95 Profit of 22,220 on sale
2025-11-04	SELL	-144	10.598	10.000	10.060	USD -1,449	41.11 Profit of 4,471 on sale
2025-11-03	SELL	-144	10.550	10.063	10.112	USD -1,456	41.27 Profit of 4,487 on sale
2025-10-28	BUY	216	9.820	10.110	10.081	USD 2,177	41.95
2025-10-24	SELL	-72	9.520	9.700	9.682	USD -697	42.30 Profit of 2,349 on sale
2025-10-15	BUY	432	9.890	10.250	10.214	USD 4,412	43.61
2025-10-02	BUY	72	7.460	7.460	7.460	USD 537	44.02
2025-09-30	BUY	144	7.170	7.480	7.449	USD 1,073	44.45
2025-08-21	SELL	-72	54.170	54.620	54.575	USD -3,929	44.40 Loss of -732 on sale
2025-07-31	BUY	216	50.440	51.590	51.475	USD 11,119	44.31
2025-06-30	SELL	-144	47.200	48.490	48.361	USD -6,964	43.49 Loss of -701 on sale
2025-06-25	SELL	-72	47.370	47.430	47.424	USD -3,415	43.41 Loss of -289 on sale
2025-06-20	SELL	-144	43.500	44.000	43.950	USD -6,329	43.38 Loss of -82 on sale
2025-05-23	BUY	72	38.930	39.080	39.065	USD 2,813	43.39
2025-05-19	SELL	-72	39.200	40.490	40.361	USD -2,906	43.53 Profit of 228 on sale
2025-05-15	SELL	-216	37.660	37.760	37.750	USD -8,154	43.64 Profit of 1,271 on sale
2025-05-12	SELL	-72	40.180	40.860	40.792	USD -2,937	43.77 Profit of 215 on sale
2025-05-09	SELL	-72	38.470	40.750	40.522	USD -2,918	43.82 Profit of 237 on sale
2025-04-30	SELL	-72	42.080	42.540	42.494	USD -3,060	44.04 Profit of 111 on sale
2025-04-24	SELL	-144	39.450	40.065	40.003	USD -5,761	44.22 Profit of 607 on sale
2025-04-17	SELL	-72	38.325	38.370	38.365	USD -2,762	44.49 Profit of 441 on sale
2025-04-15	SELL	-216	36.770	36.980	36.959	USD -7,983	44.66 Profit of 1,663 on sale
2025-04-14	SELL	-216	35.750	36.740	36.641	USD -7,914	44.75 Profit of 1,752 on sale
2025-04-09	SELL	-288	35.980	36.970	36.871	USD -10,619	45.09 Profit of 2,367 on sale
2025-04-07	SELL	-504	34.780	37.310	37.057	USD -18,677	45.35 Profit of 4,180 on sale
2025-04-04	SELL	-720	37.210	38.560	38.425	USD -27,666	45.45 Profit of 5,055 on sale
2025-03-31	BUY	72	39.070	40.685	40.524	USD 2,918	45.73
2025-03-19	SELL	-144	39.920	40.350	40.307	USD -5,804	46.36 Profit of 871 on sale
2025-03-14	SELL	-432	38.550	39.200	39.135	USD -16,906	46.67 Profit of 3,255 on sale
2025-03-13	SELL	-144	37.820	39.435	39.274	USD -5,655	46.80 Profit of 1,083 on sale
2025-03-12	SELL	-2,448	39.310	39.830	39.778	USD -97,377	46.90 Profit of 17,445 on sale
2025-03-07	SELL	-144	38.035	40.170	39.956	USD -5,754	47.33 Profit of 1,062 on sale
2025-03-06	SELL	-216	39.820	40.590	40.513	USD -8,751	47.45 Profit of 1,498 on sale
2025-03-03	SELL	-72	39.710	42.505	42.226	USD -3,040	47.81 Profit of 402 on sale
2025-02-28	SELL	-432	41.760	42.560	42.480	USD -18,351	47.91 Profit of 2,344 on sale
2025-02-26	SELL	-72	42.370	42.910	42.856	USD -3,086	48.10 Profit of 378 on sale
2025-02-25	SELL	-216	40.730	41.360	41.297	USD -8,920	48.23 Profit of 1,498 on sale
2025-02-18	BUY	360	42.825	44.570	44.395	USD 15,982	48.82
2025-02-13	BUY	72	43.600	45.010	44.869	USD 3,231	49.15
2025-02-12	BUY	72	44.270	44.390	44.378	USD 3,195	49.25
2025-02-11	BUY	216	43.230	43.940	43.869	USD 9,476	49.37
2025-02-06	BUY	648	47.110	48.220	48.109	USD 31,175	49.63
2025-01-27	BUY	72	44.890	46.750	46.564	USD 3,353	50.54
2024-12-30	BUY	360	53.020	55.500	55.252	USD 19,891	50.63
2024-12-06	BUY	288	54.310	55.035	54.963	USD 15,829	50.33
2024-12-05	BUY	72	53.500	54.000	53.950	USD 3,884	50.22
2024-12-04	BUY	360	53.060	54.540	54.392	USD 19,581	50.12
2024-11-29	BUY	360	54.430	55.370	55.276	USD 19,899	49.69
2024-11-27	BUY	288	54.240	54.600	54.564	USD 15,714	49.29
2024-11-26	BUY	72	52.840	54.330	54.181	USD 3,901	49.13
2024-11-25	SELL	-2,201	54.170	55.810	55.646	USD -122,477	48.89 Loss of -14,874 on sale
2024-11-21	BUY	393	51.860	52.090	52.067	USD 20,462	48.45
2024-11-20	BUY	234	49.820	50.980	50.864	USD 11,902	48.37
2024-11-18	BUY	936	48.540	49.290	49.215	USD 46,065	48.30
2024-11-12	BUY	624	51.890	54.810	54.518	USD 34,019	48.06
2024-11-08	BUY	390	51.780	52.000	51.978	USD 20,271	47.79
2024-11-07	BUY	1,170	50.670	52.340	52.173	USD 61,042	47.57
2024-11-06	BUY	156	51.480	51.670	51.651	USD 8,058	47.25
2024-10-31	BUY	78	46.420	47.030	46.969	USD 3,664	47.47

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MLTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	188,436	0	302,507	62.3%
2025-09-18	179,800	0	338,697	53.1%
2025-09-17	207,082	0	355,102	58.3%
2025-09-16	400,608	0	662,803	60.4%
2025-09-15	266,921	0	337,273	79.1%
2025-09-12	149,846	18	400,142	37.4%
2025-09-11	180,042	0	360,799	49.9%
2025-09-10	262,341	4,844	400,784	65.5%
2025-09-09	123,516	0	305,154	40.5%
2025-09-08	175,744	0	327,197	53.7%
2025-09-05	394,083	0	897,447	43.9%
2025-09-04	201,886	0	324,754	62.2%
2025-09-03	469,114	0	616,481	76.1%
2025-09-02	146,535	0	273,930	53.5%
2025-08-29	134,910	0	228,162	59.1%
2025-08-28	113,582	0	194,815	58.3%
2025-08-27	64,927	0	100,136	64.8%
2025-08-26	139,408	0	245,320	56.8%
2025-08-25	108,764	0	229,723	47.3%
2025-08-22	50,960	7	100,307	50.8%
2025-08-21	77,715	0	237,211	32.8%
2025-08-20	113,744	0	147,261	77.2%
2025-08-19	57,404	0	105,853	54.2%
2025-08-18	95,185	0	181,060	52.6%
2025-08-15	78,221	0	144,504	54.1%
2025-08-14	63,545	0	111,234	57.1%
2025-08-13	76,412	0	197,989	38.6%
2025-08-12	44,456	0	114,221	38.9%
2025-08-11	76,161	0	108,361	70.3%
2025-08-08	108,671	33,674	146,885	74.0%
2025-08-07	74,314	2,100	136,888	54.3%
2025-08-06	126,874	0	189,350	67.0%
2025-08-05	109,154	506	211,512	51.6%
2025-08-04	159,692	0	222,687	71.7%
2025-08-01	260,138	0	327,016	79.5%
2025-07-31	207,750	2,123	296,733	70.0%
2025-07-30	226,238	1,759	562,460	40.2%
2025-07-29	62,123	0	187,985	33.0%
2025-07-28	123,865	0	201,175	61.6%
2025-07-25	85,314	0	170,364	50.1%
2025-07-24	97,312	14	171,667	56.7%
2025-07-23	163,330	0	301,588	54.2%
2025-07-22	91,516	0	178,782	51.2%
2025-07-21	52,151	0	75,742	68.9%
2025-07-18	116,354	0	214,689	54.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE